Acquisition of the Drug Luspatercept 25 mg and 75 mg for ULSCB
About This Opportunity
TranslatedThis tender pertains to the acquisition of the pharmaceutical product Luspatercept in dosages of 25 mg and 75 mg for the Unidade Local de Saúde do Cávado e do Ave (ULSCB). The procurement is aimed at ensuring the availability of this specific medication, which is essential for treating certain medical conditions. Interested suppliers are expected to provide the required quantities of Luspatercept, adhering to the specifications outlined in the tender documents. Key requirements include compliance with regulatory standards for pharmaceutical products, timely delivery schedules, and competitive pricing. The tender is open to qualified pharmaceutical companies with experience in supplying similar medications to healthcare institutions. The location of the procurement is within the jurisdiction of ULSCB, which serves the regions of Cávado and Ave. This initiative underscores the commitment of ULSCB to enhance patient care by ensuring access to vital medications. Suppliers are encouraged to submit their proposals in accordance with the guidelines provided in the tender notice, which includes detailed instructions on documentation and submission deadlines. The successful bidder will play a crucial role in supporting the healthcare services provided by ULSCB.
This is a supplies contract in the health and medical services and information and communication technology sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 93,039.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender involves the procurement of Luspatercept, a medication available in dosages of 25 mg and 75 mg, intended for the Unidade Local de Saúde do Cávado Bragança (ULSCB) in Portugal. Luspatercept is utilized in the treatment of specific hematological conditions, making its timely availability critical for patient care within the healthcare system.
The procurement process aims to secure a reliable supply of Luspatercept to ensure that the ULSCB can continue to provide essential medical services to its patients. As part of the tender requirements, bidders are expected to demonstrate their ability to deliver the specified medication in accordance with pharmaceutical regulations and standards applicable in Portugal. This includes adherence to quality control measures, timely delivery schedules, and compliance with storage and handling protocols to maintain the integrity of the medication.
Potential suppliers should possess valid licenses and certifications that affirm their capability to operate within the pharmaceutical sector. The tender may also require bidders to provide evidence of previous experience in supplying similar products, alongside details of their logistical capabilities to meet the demands of the ULSCB.
This procurement is an integral part of maintaining healthcare services in the region, reflecting the commitment of the ULSCB to enhance patient outcomes through the provision of necessary medications. Interested parties are encouraged to review the tender documentation thoroughly and submit their proposals in accordance with the stipulated guidelines.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 16, 2026. Last refreshed 26 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Castelo Branco, EPE
Unidade Local de Saúde de Castelo Branco, EPE has issued 284 procurement notices on BidsFactory, including 0 currently open and 271 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: July 13, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to BRISTOL-MYERS SQUIBB FARMACÊUTICA PORTUGUESA S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Castelo Branco, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €93,039. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.